Lower airway microbiota compositions and diversity among ventilator-associated pneumonia patients across COVID-19 epidemic phases: a retrospective study
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.00076-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Shengyu Hao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Pneumonia, Ventilator-Associated, COVID-19, Microbiota, Lung. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Fund for Young Scholar, Shanghai Sailing Program, Three-Year Action Plan for Strengthening the Public Health System in Shanghai.
Themen: Pneumonieprophylaxe
Abstract (Originalsprache)
Ventilator-associated pneumonia (VAP) is a major cause of morbidity in critically ill patients, and the SARS-CoV-2 infection has influenced the lung microbiome. This study aimed to examine the lower respiratory tract microbiome in VAP patients during different phases of the Shanghai COVID-19 epidemic. A total of 175 patients were included and divided into pre-epidemic (Pre), during-epidemic (Dur), and post-epidemic (Post) groups for analysis. Bronchoalveolar lavage fluid and serum were analyzed using next-generation sequencing. The intensive care unit (ICU) mortality rates were 48.3% (Pre group), 60.3% (Dur group), and 28.8% (Post group). Cytokine levels were lower in the Post group compared to the Pre group. Acinetobacter , Candida , and Herpes Simplex Virus 1 ( HSV-1 ) were the most frequently detected organisms. The prevalence of Klebsiella pneumoniae , Enterococcus faecium , Aspergillus fumigatus , and HSV-1 was higher in the Dur group. α-Diversity of bacteria was significantly lower in the Dur group ( P < 0.05), indicating reduced microbiome diversity. Multivariable Cox regression analysis identified APACHE II score (hazard ratio [HR] = 1.04, P = 0.029) and maximum bacterial load (HR = 1.67, P = 0.046) as independent risk factors for ICU mortality. This study highlights changes in microbiome composition across epidemic phases, which may inform treatment strategies. IMPORTANCE With the development of next-generation sequencing technology, it is increasingly being applied in clinical practice, especially in evaluating the prognosis of severe infections and co-infections. This study characterized the composition of microorganisms in the lower respiratory tract of ventilator-associated pneumonia (VAP) patients across three phases of the COVID-19 epidemic. Our study emphasizes that the relative abundance of bacteria, fungi, and viruses in bronchoalveolar lavage fluid of VAP patients may vary with the progression of the local epidemic and host immune status. These findings provide a mechanistic basis for optimizing targeted therapies in VAP management during infectious disease outbreaks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Critical Care Medicine, Shanghai Geriatric Medical Center, Shanghai, China.
- Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
- Nutrition Department, Zhongshan Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Pan Jiang, Jieqiong Song, Ming Zhong
Förderung
- National Science Fund for Young Scholar
- Shanghai Sailing Program
- Three-Year Action Plan for Strengthening the Public Health System in Shanghai
Zitieren
APA
Hao, S., Zhou, C., Wei, Y., Wang, Y., Jiang, P., Song, J., & Zhong, M. (2025). Lower airway microbiota compositions and diversity among ventilator-associated pneumonia patients across COVID-19 epidemic phases: a retrospective study. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00076-25
Vancouver
Hao S, Zhou C, Wei Y, Wang Y, Jiang P, Song J, et al. Lower airway microbiota compositions and diversity among ventilator-associated pneumonia patients across COVID-19 epidemic phases: a retrospective study. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00076-25
BibTeX
@article{Hao2025,
author = {Hao, Shengyu and Zhou, Chujun and Wei, Yilin and Wang, Yuxian and Jiang, Pan and Song, Jieqiong and Zhong, Ming},
title = {Lower airway microbiota compositions and diversity among ventilator-associated pneumonia patients across COVID-19 epidemic phases: a retrospective study},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.00076-25}
}
EUVIMED